HomeFAB • LON
add
Fusion Antibodies PLC
Previous close
GBXÂ 9.25
Day range
GBXÂ 8.57 - GBXÂ 9.30
Year range
GBXÂ 2.80 - GBXÂ 12.00
Market cap
8.22M GBP
Avg Volume
2.47M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
(GBP) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 603.50K | 123.11% |
Operating expense | 559.50K | -16.18% |
Net income | -379.00K | 44.14% |
Net profit margin | -62.80 | 74.96% |
Earnings per share | — | — |
EBITDA | -368.00K | 43.12% |
Effective tax rate | 4.29% | — |
Balance Sheet
Total assets
Total liabilities
(GBP) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 439.00K | -9.86% |
Total assets | 1.53M | -25.75% |
Total liabilities | 469.00K | -22.35% |
Total equity | 1.06M | — |
Shares outstanding | 95.37M | — |
Price to book | 9.25 | — |
Return on assets | -64.95% | — |
Return on capital | -90.97% | — |
Cash Flow
Net change in cash
(GBP) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -379.00K | 44.14% |
Cash from operations | -376.00K | 44.34% |
Cash from investing | 2.00K | 100.00% |
Cash from financing | -6.50K | -100.79% |
Net change in cash | -380.00K | -360.27% |
Free cash flow | -206.75K | 44.70% |
About
Founded
2000
Website
Employees
27